<?xml version="1.0" encoding="UTF-8"?>	<item><status>past</status><description>&lt;span style="color : #000000"&gt;&lt;strong&gt;Orphan Disease Forum - Specialized Marketing &amp;amp; Sales: A Vision for Orphan and Targeted Therapies&lt;/strong&gt;&lt;/span&gt; When: Wednesday, June 20, 8:30 am - 9:45 am Where: &lt;span&gt;Room #209 at the Boston Convention and Exhibition Center&lt;/span&gt; &lt;span&gt;Website: &lt;a target="_blank" style="color : #0000FF ; text-decoration : underline"&gt;http://mybio.zerista.com/event/member/46585#speakers&lt;/a&gt;&lt;/span&gt; 
&lt;p&gt;&lt;span&gt;Donna LaVoie will moderate a panel at the 2012 BIO International Convention titled, "Specialized Marketing &amp;amp; Sales: A Vision for Orphan and Targeted Therapies." Biotech companies have paved the way for specialized marketing approaches for orphan diseases since the early 1990s. Some companies have developed life-changing therapies that truly change disease states. Today, biotech/pharma leaders have jumped in. But can all companies large and small find the focus for these orphan diseases and put the patient first? What are the obstacles associated with creating a specialized marketing and sales effort for orphan drugs? Gain critical understanding of how companies are employing specialized marketing and sales approaches that are patient-centric.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;&amp;nbsp;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;Speakers on the panel include:&lt;/span&gt;&lt;/p&gt;
&lt;ul style="color : #704525"&gt;
&lt;li&gt;Kyle Brown Founder &amp;amp; CEO of Innolyst&lt;/li&gt;
&lt;li&gt;Jayne Gershokowitz, Senior Director of Patient Advocacy &amp;amp; Public Policy of Amicus Therapeutics&lt;/li&gt;
&lt;li&gt;Mark Rothera, Global President of Aegerion Pharmaceuticals&lt;/li&gt;
&lt;li&gt;Rogerio Vivaldi, SVP and Head of Rare Disease Business Unit of Genzyme&lt;/li&gt;
&lt;/ul&gt;</description><event_hosts><event_hosts_item><member_name>Joshua Lang</member_name><member_id>3926861</member_id></event_hosts_item></event_hosts><maybe_rsvp_count>0</maybe_rsvp_count><waitlist_count>0</waitlist_count><updated>1340207544000</updated><rating><average>0.0</average><count>0</count></rating><group><who>Scientific Members</who><join_mode>open</join_mode><urlname>nexusproject</urlname><id>1294865</id><group_lat>42.3699989319</group_lat><group_lon>-71.0999984741</group_lon><name>Nexus Project</name></group><yes_rsvp_count>2</yes_rsvp_count><created>1333500446000</created><visibility>public</visibility><name>Specialized Marketing &amp; Sales: A Vision for Orphan and Targeted Therapies</name><id>59150862</id><headcount>0</headcount><utc_offset>-14400000</utc_offset><time>1340195400000</time><event_url>http://www.meetup.com/nexusproject/events/59150862/</event_url></item>